Preliminary Programme

8:00-9:00 Coffee
_________________________________________________________________________

Session 4: From bench to bedside
Chairs: Päivi Ojala and Anniina Färkkilä

9:00-10:00 Invited talks
Metabolic rewiring driving metastasis formation
Sarah-Maria Fendt, VIB Center for Cancer Biology

Harnessing cancer and immune cell communication to identify new therapeutic targets
Elisa Oricchio, ISREC – Swiss Institute for Experimental Cancer Research, EPFL

Transcriptional determinants of carcinogenesis
Sakari Vanharanta, University of Helsinki

10:00-10:20 Two selected talks from abstracts
_________________________________________________________________________

10:20-11:00 Coffee break and exhibition
_________________________________________________________________________

Session 5: Precision cancer medicine
Chairs: Caroline Heckman and Sirpa Leppä

11:00-12:00 Invited talks

A new lens on precision medicine… guiding therapy through single-cell direct response testing
Philipp Staber, Saarland University

Integrating Genomics and Biomarkers for Patient Selection in Phase I Precision Oncology Trials

Kristoffer Rohrberg, University Hospital of Copenhagen

Does precision cancer medicine benefit patients when standard therapy has failed? Experiences from the FINPROVE study
Katriina Jalkanen, Helsinki University Central Hospital

12:00-12:10 Selected talk from abstracts
_________________________________________________________________________

12:10-12:20 Poster prizes and conclusion of the symposium
_________________________________________________________________________

12:20 Lunch and farewell

Venue

Little Finlandia
Located in the heart of Helsinki, the Little Finlandia (Karamzininranta 4, 00100 Helsinki) offers easy access and beautiful views of a scenic park and Töölönlahti Bay.

There are easy and frequent public transport connections from the airport, bus and train stations. Tram and bus stops are in the immediate vicinity of the house. Next to the Finlandia building there is a parking garage, Aimo Park, with the following lift connections: Karamzininranta 2 and the elevator hall of the Finlandia Hall building (closest to Little Finlandia). The drive to the parking garage takes place via Karamzininranta. Parking is available for a fee.

Dinner will be served at Hesperia Ballroom at the Crowne Plaza Helsinki (Mannerheimintie 50, 00260 Helsinki).

Registration

Registration is open until 3.9.2025. The deadline for the call of abstracts is 15.8.2025.
Register here.

Symposium fees
Please note that a registration fee of 35€ is required from all the participants to attend the event. For the sponsors, the registration fee is included in the sponsorship agreement. The registration fee covers two lunches, coffee breaks, and cloak room services during the symposium.

A dinner fee of 30€ applies if you wish to join the dinner on 25.9.

Credits
The symposium is suitable as a theoretical course-based training in the fields of pathology, clinical hematology, and oncology, with a duration of 8 hours at the University of Helsinki. The training can also be included in the theoretical studies of a Doctor of Medicine or Doctor of Philosophy degree, corresponding to 0.7 ECTS credits.

Please come back for updates!

Sponsors

Sponsor logos: Abbvie, AstraZeneca, Bayer, Curium, Merck, Roche, Syöpäsäätiö

Join us in supporting innovation and collaboration at Mission Possible. For sponsorship opportunities, please contact us at ican-symposium@helsinki.fi.

The exhibition area will be located in the Little Finlandia foyer.


Scientific Organizing Committee
Anniina Färkkilä (Chair), Assoc. Prof., University of Helsinki and Helsinki University Hospital
Sirpa Leppä (Chair), Professor, University of Helsinki and Helsinki University Hospital
Caroline Heckman, Research Director, University of Helsinki
Tuomas Mirtti, Professor, University of Helsinki and Helsinki University Hospital
Päivi Ojala, Professor, University of Helsinki
Esa Pitkänen, FIMM-EMBL Group Leader, University of Helsinki
Thomas Hackman, iCAN Patient and Citizen Advisory Board

Tiina Vesterinen, Managing Director, Finnish Cancer Institute

iCAN core
Helene Wahl, Satu Sankkila, Marketta Liljeström